Terry Chin MD Ph.D.

Pediatric Asthma & Allergic Conditions

Physician

2801 Atlantic AveLong Beach, CA 90806
Phone+1 562-933-8740
Fax+1 562-933-8744

Dr. Chin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chin's full profile Already have an account?

Summary

Dr. Terry Chin is an Allergy and Immunology specialist based in Long Beach, CA, with a subspecialty in pediatric asthma and allergic conditions. He completed his pediatrics residencies at UCLA and the University of California, Irvine. Dr. Chin has contributed to several publications, including studies on cystic fibrosis and exercise-induced pulmonary function changes, and has been involved in clinical trials like the study of ataluren for cystic fibrosis. He has been recognized with honors such as the Physician Excellence in Leadership from MemorialCare in 2018 and the Munzer Award for Excellence in Teaching and Research.

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1983 - 1986
University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 1980 - 1983
Baylor College of MedicineClass of 1977

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1982 - 2027
TX State Medical License 1978 - 1984
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Physician Excellence in Leadership MemorialCare, 2018
Tribute to Champions of Hope 2014
Applause Award Honoree Long Beach Memorial Health System, 2013

Clinical Trials

Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)
COMPLETED
PHASE3

Publications & Presentations

PubMed

32 citations
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR ...
Patrick A. Flume, Reta Fischer Biner, Damian G Downey, Cynthia A. Brown, Manu Jain
The Lancet. Respiratory Medicine. 2021-02-10
7 citations
Wiskott-Aldrich Syndrome: Description of a New Gene Mutation With Normal Platelet Volume.
Leila Yoonessi, Inderpal Randhawa, Eliezer Nussbaum, Samah Saharti, Paul C.M. Do
Journal of Pediatric Hematology/oncology. 2015-10-01
3 citations
Reply: FEV1 Can Be Associated with Reduced Values after Vigorous Exercise in Healthy Adolescents
Alladdin Abosaida, Jen Jen Chen, Eliezer Nussbaum, Szu-Yun Leu, Terry Chin
Annals of the American Thoracic Society. 2015-07-23

Journal Articles

Long-term safety and efficacy of tezacaftor-Carter in individuals with cystic fibrosis aged 12 years or older
Flume et al, Lancet Respiratory Medicine, 7/2021